Sonoma Pharmaceuticals (SNOA) Cash from Operations: 2010-2013
Historic Cash from Operations for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Mar 2013 value amounting to -$1.0 million.
- Sonoma Pharmaceuticals' Cash from Operations rose 20.55% to -$1.0 million in Q1 2013 from the same period last year, while for Mar 2013 it was $1.1 million, marking a year-over-year increase of 128.52%. This contributed to the annual value of -$88,000 for FY2025, which is 96.33% up from last year.
- Sonoma Pharmaceuticals' Cash from Operations amounted to -$1.0 million in Q1 2013, which was up 4.92% from -$1.1 million recorded in Q4 2012.
- In the past 5 years, Sonoma Pharmaceuticals' Cash from Operations registered a high of $4.6 million during Q3 2012, and its lowest value of -$1.6 million during Q4 2010.
- For the 3-year period, Sonoma Pharmaceuticals' Cash from Operations averaged around -$328,444, with its median value being -$1.0 million (2013).
- Within the past 5 years, the most significant YoY rise in Sonoma Pharmaceuticals' Cash from Operations was 585.20% (2012), while the steepest drop was 1,675.68% (2012).
- Over the past 4 years, Sonoma Pharmaceuticals' Cash from Operations (Quarterly) stood at -$1.6 million in 2010, then increased by 23.45% to -$1.2 million in 2011, then rose by 12.16% to -$1.1 million in 2012, then grew by 20.55% to -$1.0 million in 2013.
- Its Cash from Operations stands at -$1.0 million for Q1 2013, versus -$1.1 million for Q4 2012 and $4.6 million for Q3 2012.